Endometrial Ablation Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Endometrial Ablation Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The endometrial ablation devices market studied was projected to grow with a CAGR of 5.2% over the forecast period.

As a result of the COVID-19 pandemic, the healthcare sector has faced great obstacles. During the COVID-19 pandemic, all outpatient treatments were postponed or restricted to reduce the danger of viral transmission, as most chronic therapies were deemed non-urgent. According to the study titled "Endometriosis Surgery during the First Wave of the COVID-19 Pandemic: A Brazilian Single Institution Experience" published in October 2021, endometriosis surgery throughout the fourth, fifth, and sixth months of pandemic constraints. Many endometriosis patients had put off consultations, diagnostic tests, and elective therapeutic operations. Thus, the decline in endometrial surgeries during COVID-19 significantly impacted the market growth. However, owing to the resumption of endometrial surgeries and a decline in COVID-19 cases, the market is likely to bolster its pre-pandemic levels soon.

The major factor attributing to the growth of the market is the increase in the prevalence of gynecological disorders like cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD or polycystic ovarian disease in women. According to the World Health Organization Updates in February 2022, cervical cancer is the fourth most common cancer in women worldwide, with 604 000 new cases and 342 000 deaths by 2020. In 2020, low- and middle-income countries will account for nearly 90% of new cases and deaths worldwide. Thus, the growing prevalence of gynecological diseases is expected to boost market growth over the forecast period.

The increasing developments made among the key players in the ablation segment are also adding to the growth of the market. For instance, in November 2021, Hologic, Inc. unveiled the NovaSure V5 global endometrial ablation (GEA) device at the 50th Global Congress of the American Association of Gynecologic Laparoscopists (AAGL) on Tuesday (November 14-17). However, stringent regulatory policies constrain market growth.

Key Market TrendsRadiofrequency Endometrial Ablation Devices Segment is Expected to Dominating Market

The largest share of the radiofrequency endometrial ablation devices is accounted to the factors such as high safety & fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. Apart from the advantages of the devices, the factors driving the segment growth are the increasing prevalence of cervical cancer, menorrhagia, and other gynecology disorders.

According to the study titled "Radiofrequency endometrial ablation with a novel endometrial tip for the management of heavy menstrual bleeding and abnormal uterine bleeding: a prospective study" published in July 2020, the safety and efficacy of a radiofrequency ablation system with a new endometrial tip (RFA-EMT) for heavy menstrual bleeding (HMB) or abnormal uterine bleeding (AUB) were 97.4% and 100%, respectively. Thus, the higher safety and efficacy of the radiofrequency ablation system is expected to increase segment growth over the forecast period.

Moreover, the growing prevalence of endometrial cancer is expected to boost segment growth. As per American Cancer Society 2022 update, there were more than 600,000 survivors of endometrial cancer in the United States. As per the same source, around 65,950 new cases of cancer of the body of the uterus (uterine body or corpus) are expected to be diagnosed in 2022. Thus, the growing prevalence of endometrial cancer is expected to rise in demand for endometrial ablation devices.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The endometrial ablation devices market in this region witnessed rapid technological advancements. Escalating cases of gynecological disorders, rising healthcare infrastructure, and strong establishment of major market players to offer innovative endometrial ablation devices are accountable for promoting the endometrial ablation devices market in this region. According to the study titled "Endometriosis Is Undervalued: A Call to Action" published in May 2022, endometriosis is a chronic inflammatory pain disorder that affects 6.5 million women in the United States each year. Hence growing prevalence of endometritis in the country it is expected that the demand for endometrial ablation devices is expected to increase over the forecast period.

Moreover, the growing prevalence of various gynecological diseases further supports the growth of the market. According to the Cervical Cancer Statistics 2020, invasive cervical cancer was diagnosed in approximately 14,100 women in the United States. Hence, the growing prevalence of cervical cancer is expected to boost market growth over the forecast period.

Additionally, growing product launches by the key market players support market growth. For instance, in November 2020, Hologic reported the release of the Omni suite Omni 30° hysteroscope along with Omni 4K video technology for enhancing diagnostic and surgical hysteroscopy. The new Omni hysteroscope provides diagnostic and surgical adaptability thanks to three interchangeable sheaths and a long working length that allows the procedure to be tailored to the patient's anatomy.

Thus, given the above-mentioned facts, the studied market is expected to propel in the United States over the forecast period

Competitive Landscape

The Endometrial Ablation Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Cooper Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, Minerva Surgical, Inc., AngioDynamics, Hologic, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.